𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A phase II trial of biweekly high dose gemcitabine for patients with metastatic pancreatic adenocarcinoma

✍ Scribed by Herbert Ulrich-Pur; Gabriela V. Kornek; Markus Raderer; Karin Haider; Werner Kwasny; Dieter Depisch; Renate Greul; Bruno Schneeweiss; Gwendolyn Krauss; Josef Funovics; Werner Scheithauer

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
81 KB
Volume
88
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A Phase II trial of high dose epirubicin
A Phase II trial of high dose epirubicin in patients with advanced breast carcinoma
✍ Kathy D. Miller; Nikhil Munshi; David Loesch; Lawrence H. Einhorn; George W. Sle πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 82 KB πŸ‘ 2 views

## BACKGROUND. Anthracyclines are among the most active drugs in the treatment of breast carcinoma and exhibit a steep dose-response curve in vitro. This trial was performed to determine the efficacy and toxicity of epirubicin in the treatment of patients with advanced breast carcinoma when adminis

Outpatient combination chemoimmunotherap
Outpatient combination chemoimmunotherapy for patients with metastatic melanoma : Results of a Phase I/II trial
✍ Mohammed Kashani-Sabet; Richard W. Sagebiel; Henry E. Collins; Alan B. Glassberg πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 75 KB πŸ‘ 1 views

## BACKGROUND. Few studies have examined the feasibility, safety, and efficacy of an outpatient biochemotherapy regimen of low dose, subcutaneously administered interleukin-2 (IL-2) for patients with metastatic (Stage IV) melanoma. ## METHODS. Nineteen patients were treated with intravenous cispl

A phase II trial of extracorporeal plasm
A phase II trial of extracorporeal plasma immunoadsorption of patient plasma with prosorba columns for treating metastatic breast cancer
✍ David W. Fennelly; Larry Norton; Mario Sznol; Thomas B. Hakes πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 350 KB πŸ‘ 1 views

Background. Circulating immune complexes (CIC) have been implicated as a cause of malignancy-associated immunosuppression and disease progression. Previous attempts to remove CIC by pheresis or immunoadsorption over a Staphylococcus aureus protein A column have resulted in a few clinical responses,